AI-generated summary
The authors report a prospective, single-site pilot study of intense pulsed light treatment followed by meibomian gland expression in adults with dry eye disease and upper lid gland dysfunction. Across four treatments, they report improved tear breakup time and lower symptom scores, with no adverse events in the trial. The study's small pilot design and single site limit how far these findings can be generalized.
- Who or what was studied
- Adults with dry eye disease and upper lid Meibomian gland dysfunction
- Wavelengths
- 590 nm
- Limits stated in the abstract
- The abstract describes a pilot, single-site prospective study, and it does not report a control group or a participant total.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 590 nm
- Energy density (fluence)
- 10 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Pilot study, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.